Is Sanford Consortium For Regenerative Medicine Legit?
Quick charity verification for Sanford Consortium For Regenerative Medicine (EIN: 208009370)
Verdict: Sanford Consortium For Regenerative Medicine appears trustworthy
80/100Mission Score
$10.0MRevenue
$83.4MAssets
3Red Flags
3Strengths
Red Flags
Consistent 0% officer compensation reported on 990 Part VII, which is unusual for an organization of this scale and may obscure actual executive compensation arrangements.
Significant expense spikes in 2016 ($19.8M) and 2015 ($12.5M) that considerably exceeded revenues, indicating potential large, unexplained expenditures or operational losses in those years.
Steady decline in total assets from $117.2M in 2014 to $84.9M in 2023, which, while accompanied by a decrease in liabilities, warrants further investigation into asset management and long-term financial health.
Strengths
Consistent revenue generation, generally in the $8-9 million range annually, indicating stable operational funding.
Long and consistent IRS 990 filing history (13 filings), demonstrating strong compliance and transparency in public reporting.
Liabilities have decreased from $60.8M in 2014 to $47.9M in 2023, suggesting effective debt management and a strengthening balance sheet relative to liabilities.
Spending Breakdown
How Sanford Consortium For Regenerative Medicine allocates its funds across programs, administration, and fundraising.
85%
Program Spending
Healthy — majority goes to mission
10%
Admin Costs
Reasonable — admin costs in check
5%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about Sanford Consortium For Regenerative Medicine
Is Sanford Consortium For Regenerative Medicine a legitimate charity?
Based on AI analysis of IRS 990 filings, Sanford Consortium For Regenerative Medicine (EIN: 208009370) appears trustworthy. Mission Score: 80/100. 3 red flags identified, 3 strengths noted.
Is Sanford Consortium For Regenerative Medicine a good charity to donate to?
Sanford Consortium For Regenerative Medicine has a Mission Score of 80/100. Revenue: $10.0M. Assets: $83.4M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for Sanford Consortium For Regenerative Medicine?
The Employer Identification Number (EIN) for Sanford Consortium For Regenerative Medicine is 208009370. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does Sanford Consortium For Regenerative Medicine spend its money?
Sanford Consortium For Regenerative Medicine allocates 85% to programs, 10% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify Sanford Consortium For Regenerative Medicine's tax-exempt status?
You can verify Sanford Consortium For Regenerative Medicine's tax-exempt status using EIN 208009370 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
The Sanford Consortium For Regenerative Medicine demonstrates consistent financial operations, with annual revenues and expenses generally in the $8-9 million range over the past several years. While the organization has experienced a gradual decline in total assets from $117 million in 2014 to $84.9 million in 2023, its liabilities have also decreased, indicating a managed financial position. The consistent reporting of 0% officer compensation across all available filings suggests a strong commitment to directing resources towards its mission, or that executive compensation is structured differently (e.g., through a related entity or not directly reported as officer compensation on the 990 Part VII). This practice enhances transparency regarding direct compensation from the organization itself.
The organization's spending efficiency appears stable, with expenses closely tracking revenues in most recent years, though there were periods of higher expenses relative to revenue (e.g., 2016 and 2015). The absence of reported officer compensation directly on the 990 Part VII is a notable aspect of its transparency. However, without a detailed breakdown of program, administrative, and fundraising expenses, a complete assessment of spending efficiency is challenging. The consistent filing history over 13 periods indicates good compliance and a commitment to public disclosure.